Skip to main content

Table 4 Comparative analysis of demographic and pathological information

From: Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy

 

No. of bb genotype pts.

No. of a-allele carriers

P

Gender

   

   Female

35

7

P = 0.63

   Male

52

14

 

Age

   

   <70

64

15

P > 0.9

   70 or older

23

6

 

ECOG PS

   

   0

17

6

P = 0.38

   1

70

15

 

Smoking Status

   

   Never or Light

29

7

P > 0.9

   Current or Former

58

14

 

Clinical Stage

   

   III

31

5

P = 0.44

   IV

56

16

 

Histology

   

   Adenocarcinoma

68

18

P = 0.56

   Non-adenocarcinoma

19

3

 

EGFR mutation

   

   Activating mutation

19

2

P = 0.30

   Wild type

9

4

 

   Unknown

59

15

 

Thoracic radiotherapy

   

   Yes

17

3

P = 0.76

   No

70

18

 
Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us